about
Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug deliveryNanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained deliveryUltrasound-enhanced ocular delivery of dexamethasone sodium phosphate: an in vivo study.Safety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbits.Intrascleral drug delivery to the eye using hollow microneedles.Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model.Sirolimus-loaded CaP coating on Co-Cr alloy for drug-eluting stentSafety evaluation of ocular drug delivery formulations: techniques and practical considerations.Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies.In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing.Ocular delivery systems for topical application of anti-infective agents.Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.Characterization of silicone pressure-sensitive adhesive episcleral implant for drug delivery.Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye.Hydrogel Ring for Topical Drug Delivery to the Ocular Posterior Segment.Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery
P2860
Q27007119-17C92AE1-0B86-4881-BCF8-1C933DF83214Q28088743-CFA7464E-9335-4577-AD33-9C7F45C99FE6Q30436895-9E5D8C2B-F87E-457F-91D7-1B93C35677B9Q33830339-9441AE68-8387-4FDE-8E3C-8E27CAEC682CQ33978350-13A28132-A299-4B8A-899C-7F3869B30347Q33986007-191FCC13-5AEB-42EC-BB8D-376982F52F89Q36939424-6B19573C-777A-4F7C-A830-61506A6F92E6Q37109083-ECEE9ACB-6C36-412F-8B46-03A4BC230E2EQ37425217-0EF9FCC6-9884-4867-93FF-BD69802298FFQ38017707-92F0B14F-284B-4449-8AEE-EBBDF4C05AAAQ38577846-2C76CFB5-E979-4C3B-B769-8CB6FFB4839CQ38769853-041B618E-2A3B-4F53-AE28-86511274DBE9Q40999904-DFC9ED20-0D02-48E5-B9AD-C08242184FABQ42034917-876A609D-39A6-4A8F-9C66-BF07938FAEEDQ51823268-8BCA109F-E549-46A3-8221-2B59ABAC0CC7Q58608160-E4E3B084-484C-44E4-930C-A93996B3D24A
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Drug delivery from ocular implants.
@ast
Drug delivery from ocular implants.
@en
type
label
Drug delivery from ocular implants.
@ast
Drug delivery from ocular implants.
@en
prefLabel
Drug delivery from ocular implants.
@ast
Drug delivery from ocular implants.
@en
P2093
P2860
P356
P1476
Drug delivery from ocular implants.
@en
P2093
Eiji Sakurai
Hideya Kimura
Tsutomu Yasukawa
Yasuhiko Tabata
Yuichiro Ogura
P2860
P304
P356
10.1517/17425247.3.2.261
P407
P577
2006-03-01T00:00:00Z